Ali Behbahani, Director, 10% Owner at Monte Rosa Therapeutics, Inc. (GLUE), bought 1,719,002 shares at $19.00 ($19.9M) on 2021-06-28, disclosed to the SEC on 2021-06-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 669,002 | $0 | 0.0% |
| 2 | $19.00 | 1,050,000 | $19.9M | 100.0% |
| Total | $11.61 avg | 1,719,002 | $19.9M | 100% |
| Filing → |
| ADAP | SELL | 2025-08-19 | $342K | — | Filing → |
| MBX | BUY | 2024-09-17 | $8.0M | — | Filing → |
| SVRA | BUY | 2023-07-19 | $1000K | — | Filing → |